Coronary stents sales will rise through 2036, driven by drug-eluting stents at 33.2% share of the product type segment in 2025. Hospitals hold 27.1% share of the end user segment in 2025. The market is expected to reach USD 37.5 billion in 2026 and USD 64.6 billion by 2036.